• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- NEWS BRIEF May 13, 2026

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
www.cidrap.umn.edu/all-news

Quick takes: Pandemic flu preparedness, multiple-pathogen dashboard, more measles in Utah



News brief

35 minutes ago.
Stephanie Soucheray, MA
Topics

Pandemic Influenza

Public Health

Measles
  • Yesterday the Pan American Health Organization (PAHO) announced an agreement with CSL Seqirus aimed at securing a reserved share of pandemic influenza vaccine production for PAHO member states in Latin America and the Caribbean in the case of a future influenza pandemic. “This agreement is a direct response to the hard lessons of COVID-19 and a major step forward in strengthening health security and pandemic preparedness across the Americas,” said PAHO Director Jarbas Barbosa, MD, MPH, PhD, in a press release. Barbosa said the deal will help put Latin and Caribbean countries on more equal footing to access future vaccines.
  • ARUP Laboratories announced today the launch of its National Infectious Disease Test Positivity Trends Dashboard, the first tool developed by a US reference laboratory to track laboratory test-positivity trends for multiple pathogens. The dashboard is based on deidentified test results. According to a statement from the company, the dashboard will help clinical laboratories, medical directors, and clinicians detect unusual patterns, seasonal shifts, and emerging infectious disease activity earlier. Maps and charts will be refreshed weekly, and the dashboard features pathogen-specific pages.
  • Utah has more measles cases in an outbreak that has simmered in the state for more than nine months. There are now 466 cases recorded this year, and 663 in the 2025-26 outbreak. Officials have confirmed 29 cases in the past three weeks. The Southwest health district has recorded the most cases, with 263 (56% of all infections).
 
Back
Top Bottom